Cannell Capital - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 62 filers reported holding OVID THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cannell Capital ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$58,360
+38.7%
22,6200.0%0.01%
+37.5%
Q4 2022$42,073
+0.2%
22,6200.0%0.01%
-20.0%
Q3 2022$42,000
+223.1%
22,620
+280.2%
0.01%
+233.3%
Q2 2022$13,0005,9490.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,483,059$9,982,0005.39%
EcoR1 Capital, LLC 6,082,200$24,450,0001.08%
BVF INC/IL 6,417,551$25,799,0000.97%
Fairpointe Capital LLC 71,700$288,0000.44%
CHI Advisors LLC 247,510$995,0000.20%
DCF Advisers, LLC 109,001$438,0000.19%
Artal Group S.A. 2,500,000$10,050,0000.18%
Ikarian Capital, LLC 1,124,872$4,522,0000.15%
HighVista Strategies LLC 40,920$164,0000.12%
Tekla Capital Management LLC 372,733$1,498,0000.05%
View complete list of OVID THERAPEUTICS INC shareholders